Posted by Theresa Gralinski, Marketing Director at CorDynamics on June 29th, 2011
Big City, Big Advantages for Drug Discovery and Development
The heart of our business is in the heart of the city of Chicago. The CorDynamics offices and laboratories are mere miles from McCormick Place West where the DIA 2011 Annual Meeting will be held next week.
A contract research organization specializing in cardiovascular drug discovery, safety and efficacy in Chicago? Why Chicago?
We believe the city of Big Shoulders gives us big advantages.
Proximity to world-class universities, thought leaders and talent—The University of Chicago, University of Illinois at Chicago, Northwestern University, Loyola University and DePaul.
Access to O’Hare International Airport and daily flights to almost anywhere in the world.
Centrally located in the Midwest for access to clients on both Coasts and worldwide.
Deep roots in the community, where we are proud to attend and sponsor events— 15th Running of the Chicago Half Marathon in September and the Rock for Rare disease Jesse Malin benefit concert in July.
Not to mention, Chicago is a great place to welcome guests and colleagues.
If you’ll be in town for the DIA conference, or any other time, let us know. We’d love to meet with you, give you a tour of our facilities and show you some of our favorite Chicago hot spots.
Filed under: About Us, Drug Discovery Services, Drug Safety Services |
Posted by Theresa Gralinski, Marketing Director at CorDynamics on May 01st, 2011
A rock concert for rare diseases? What’s to sing about?
The Beat Batten & Rock Rare Disease concert given by Jesse Malin and the St. Marks Social in Chicago on July 23 will celebrate hope for awareness, new drug discoveries and specifically Hope4Bridget.
Bridget Kennicott was a spirited, rambunctious three-year old with delayed speech. Nothing rare about that. However her mother, an elementary school teacher and a breast cancer survivor, sensed there was something more. Then the seizures hit. After a marathon of doctors Bridget’s final diagnosis was devastating—Late Infantile Neuronal Ceroid Lipofuscinosis (LINCL) often referred to as Batten Disease. The children slowly deteriorate; the disease is fatal; there is no cure. Research is ongoing and some experimental drugs are currently in a limited clinical trial.
Through friends of friends, we heard about Bridget’s story and have followed her family’s journey to find treatments, causes, comfort and when all else fails—hope.
Developing lifesaving drug therapies for diseases of all magnitudes is what drives us day in and day out at CorDynamics. So why not carry that tune into our nightlife and back the band—so to speak?
Join us. If not that night, please join us in spirit, dedication and most of all—hope. Because where there is hope, there is always a glimmer of joy.
Filed under: Drug Discovery Services, Events |